BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will be on a panel titled "Update on Capital Availability for Indiana Companies" at Burrill's Indiana Life Sciences Forum in Indianapolis, IN
News | 10. 21. 2008
